A pattern that has accelerated in 2025–2026 healthcare procurement: a healthtech vendor with a strong SOC 2 Type II report wins the technical review and the clinical workflow review, gets through legal, and stalls at the vendor risk management step. The reviewer comes back with one question — "Do you have HITRUST certification?" — and the deal goes cold while the vendor spends 6–12 months on a certification they didn't think they needed.
The reason is structural, not arbitrary. SOC 2 reports describe the control environment and are evaluated against the Trust Services Criteria — broad, principles-based, generally applicable. HITRUST is purpose-built for healthcare vendor risk management: HIPAA Security Rule requirements are natively mapped at the control level, the Shared Responsibility Matrix is the framework's native answer to Business Associate vendor scoping, and the HITRUST-issued certification carries a level of assurance that hospital systems' and payers' vendor risk teams have built their procurement processes around.
The May 2026 HIPAA Security Rule Overhaul amplifies this pattern. The Overhaul moves HIPAA from broadly principles-based to prescriptive control requirements — specific MFA expectations, encryption at rest, vulnerability scanning cadence, asset inventory requirements, network segmentation expectations, incident response testing. The Overhaul significantly raises the bar for what "compliant with HIPAA" actually means in regulatory enforcement terms, and HITRUST CSF v11.7 already maps to that new bar.
The arithmetic from a cold start: e1 in 3–5 months (~$35K typical), i1 in 6–9 months (~$70K), r2 in 9–12 months (~$100K+). With an existing SOC 2 program: 50–60% control overlap accelerates the timeline by roughly 30%. The 2026 reality is that "we'll do HITRUST when a customer requires it" leaves the vendor 6–12 months away from a usable certification — long enough for the deal to die.